« Previous
Next »
Lung Cancer
Volume 76, Issue 3
, Pages 478-485
, June 2012
Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analyses
To access this article, please choose from the options below
PII: S0169-5002(11)00679-9
doi: 10.1016/j.lungcan.2011.12.015
© 2012 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Lung Cancer
Volume 76, Issue 3
, Pages 478-485
, June 2012
